Klebsiella pneumoniae is a Gram-negative bacterium that colonizes the human gut and mucosal surfaces, but it can cause severe, life-threatening infections including pneumonia, bloodstream infections, meningitis, and liver abscesses. The bacterium has long been a fixture of hospital-acquired infection surveillance because of its remarkable capacity to acquire and disseminate antibiotic resistance genes via mobile genetic elements, particularly plasmids. Carbapenems, a class of last-resort beta-lactam antibiotics reserved for the most serious multidrug-resistant infections, have historically been the therapeutic mainstay for treating serious K. pneumoniae infections. The emergence of strains resistant to these agents has therefore been recognized by the World Health Organization as a critical public health threat requiring urgent global attention.

The research team, led by Montaser M. Y. Amro, Aysegul Bostanci, and Buket Baddal of Near East University’s Faculty of Medicine and DESAM Research Institute, set out to determine the prevalence of beta-lactamase genes and hypervirulence-associated markers among clinical carbapenem-resistant K. pneumoniae isolates circulating in Cyprus. Their methodology combined classical microbiological phenotyping with targeted molecular detection of resistance and virulence determinants, providing a comprehensive snapshot of what is circulating in a single tertiary care facility.

The isolates were first identified to the species level and subjected to antimicrobial susceptibility testing using the VITEK-2 automated system, a widely adopted platform in clinical microbiology laboratories. Carbapenem resistance was confirmed using the Modified Hodge test, a phenotypic assay in which a carbapenem-susceptible indicator strain is used to detect carbapenemase production by the test isolate. The results were striking: 75 of the 96 isolates, or 78.1 percent, were confirmed as carbapenem-resistant K. pneumoniae by the Modified Hodge test. This figure alone underscores the substantial burden of carbapenem resistance within the hospital’s patient population.

Molecular characterization of the carbapenemase genes revealed a clear predominance of blaOXA-48, which was detected in 84.0 percent of the carbapenem-resistant isolates. The OXA-48-type carbapenemases, originally described in Turkey and now widespread across Europe, the Middle East, and North Africa, hydrolyze carbapenems and penicillins but spare extended-spectrum cephalosporins. Their dominance in this Cypriot cohort is consistent with regional epidemiological patterns documented by the European Centre for Disease Prevention and Control, which has repeatedly highlighted OXA-48 as the most prevalent carbapenemase in Enterobacterales across the EU and EEA.

The remaining carbapenemase determinants were less frequent but clinically significant. The metallo-beta-lactamase gene blaIMP was found in 8.0 percent of isolates, blaVIM in 4.0 percent, and blaNDM in 2.7 percent. New Delhi metallo-beta-lactamases are particularly feared because they hydrolyze nearly all beta-lactam antibiotics, including carbapenems, and are often embedded in plasmids that carry additional resistance determinants. Perhaps most concerning was the detection of co-existing carbapenemase genes in eight isolates. These strains harbored combinations of blaOXA-48 with either blaNDM, blaIMP, or blaVIM, meaning they carry both a serine carbapenemase and a metallo-beta-lactamase on the same genetic background. Such co-carriage severely constrains therapeutic options and increases the risk that treatment with any single beta-lactam-beta-lactamase inhibitor combination will fail, as the two enzyme classes have complementary hydrolysis spectra that can compensate for each other’s weaknesses.

The hypervirulence component of the investigation is what elevates this study from a routine resistance survey to a report of genuine epidemiological significance. Hypervirulent K. pneumoniae is a distinct pathotype characterized by enhanced ability to cause invasive, metastatic infections in otherwise healthy individuals. Classical hypervirulent strains were first recognized in East Asia, where they caused dramatic cases of community-acquired liver abscess with metastatic spread to the eyes, central nervous system, and other sites. These strains typically overproduce capsular polysaccharide, giving colonies a hypermucoviscous appearance, and produce additional iron-scavenging systems that enhance survival within the host.

To assess hypervirulence potential, the researchers performed the string test, a simple phenotypic assay in which a bacterial colony is touched with an inoculation loop and the resulting string is measured; a positive result, defined as a string extending more than 5 millimeters, indicates hypermucoviscosity associated with hypervirulent potential. They also used conventional polymerase chain reaction to screen for three hypervirulence-associated genes: iucA, which encodes a key enzyme in aerobactin synthesis; peg-344, a metabolic transporter gene associated with hypervirulent strains; and iroB, involved in salmochelin siderophore synthesis.

Of the 75 carbapenem-resistant isolates, 32, or 42.7 percent, exhibited the hypermucoviscous phenotype on string testing. This is a remarkably high proportion for a carbapenem-resistant population and suggests that hypervirulence traits are well established within the resistant strains circulating at the hospital. At the genetic level, the aerobactin synthesis gene iucA was detected in 44 isolates, representing 58.7 percent of the carbapenem-resistant cohort. Aerobactin is a siderophore, an iron-chelating molecule that allows the bacterium to scavenge iron from its host, and it is widely regarded as one of the most reliable molecular markers of hypervirulent K. pneumoniae. Previous studies have shown that aerobactin-positive strains exhibit significantly enhanced virulence in experimental infection models compared to aerobactin-negative strains.

Interestingly, the peg-344 and iroB genes were not detected in any of the examined isolates. This finding suggests that the Cypriot strains possess a partially assembled hypervirulence genetic repertoire rather than the complete complement typically found in classical hypervirulent K. pneumoniae clones. It also highlights an ongoing debate within the field regarding the prudent use of the term “hypervirulence” when applied to carbapenem-resistant isolates, as some researchers have cautioned that partial virulence gene carriage may not equate to the clinical severity associated with classical hypervirulent strains. Nevertheless, the combination of carbapenem resistance with aerobactin production and a hypermucoviscous phenotype in nearly half of the resistant isolates represents a convergence of traits that has historically been associated with worse patient outcomes, including higher mortality rates in bloodstream and intra-abdominal infections.

The convergence of hypervirulence and carbapenem resistance in a single strain is a relatively recent phenomenon in the evolution of K. pneumoniae. For many years, these two traits appeared to occupy separate evolutionary niches: classical multidrug-resistant hospital strains tended to be less virulent, while hypervirulent community strains remained susceptible to most antibiotics. However, reports from China and increasingly from Europe have documented the emergence of strains that carry both resistance determinants and virulence plasmids, often through horizontal transfer of virulence plasmids into resistant backgrounds or acquisition of resistance plasmids into virulent clones. The Cypriot findings add the eastern Mediterranean island to the growing list of regions where this convergence has been documented.

The clinical implications are substantial. Carbapenem-resistant K. pneumoniae infections already carry high mortality because of limited treatment options, typically restricted to combinations of tigecycline, colistin, ceftazidime-avibactam, and meropenem in various permutations. Adding hypervirulence traits to this picture could make infections even more difficult to manage, particularly in vulnerable patient populations such as the elderly, immunocompromised individuals, and those with indwelling medical devices. The presence of metallo-beta-lactamases in some isolates further complicates the therapeutic landscape, as these enzymes are not inhibited by newer beta-lactamase inhibitors such as avibactam.

The Cyprus study also carries regional significance given the island’s position as a crossroads between Europe, the Middle East, and North Africa, and given its proximity to countries with high endemic rates of carbapenem resistance. Cross-border movement of resistant organisms through medical tourism, patient transfer, and population mobility is well documented, and Cyprus’s role as both a destination and a transit point makes it a potentially important location for monitoring the spread of these convergent strains.

The authors of the study emphasize that this is the first report describing carbapenem-resistant K. pneumoniae isolates with hypervirulence-associated characteristics in Cyprus and stress the need for continuous molecular surveillance and stringent infection control measures to prevent further dissemination within the healthcare environment. Their findings serve as a stark reminder that the evolution of dangerous bacterial pathogens does not respect national boundaries and that vigilant, genomics-informed surveillance remains one of the most effective tools available for early detection and containment of emerging threats. As antimicrobial resistance continues to climb globally, studies such as this one provide critical baseline data that will inform future monitoring, infection prevention strategies, and therapeutic decision-making in the region and beyond.

To quantify occupational exposure with real statistical power, the team recruited 96 pig farmers and 97 residents drawn from the same rural communities. The residents shared the farmers’ geography, water systems and broadly similar diets but had no direct contact with swine, which made them an unusually clean control group: direct animal exposure became the variable of interest. The researchers also sampled 238 pigs from the same farms, yielding a three-way comparison of pigs, farmers and residents. Each human volunteer provided fecal samples and completed questionnaires covering age, sex, antibiotic use and health status, under protocols approved by the Medical Ethics Committee of Sichuan University. Shotgun metagenomics — the sequencing of all of the DNA in a sample rather than a single marker gene — allowed the researchers to inventory not only which microbial species were present but which functional genes they carried, including the complete collection of antibiotic resistance genes known as the resistome. In parallel, the team cultured E. coli from all three groups: 665 pig isolates, 80 from farmers and 88 from residents.

The compositional differences between farmers and residents were unambiguous. Farmers showed reduced gut alpha-diversity, meaning their intestinal ecosystems contained fewer distinct species and were less evenly balanced, and they scored lower on the Gut Microbiome Health Index, a species-based metric that associates community composition with overall health status. A multivariate dispersion analysis indicated that farmers and residents differed in composition rather than merely in variability, and supplementary analyses accounted for age and sex. The functional shifts were equally telling. Farmers were depleted of several taxa that degrade dietary fiber and produce short-chain fatty acids — acetate, propionate and, above all, butyrate, the preferred fuel of the cells lining the colon and a key regulator of inflammation and immune tone. In their place, the researchers found organisms and metabolic pathways geared toward exploiting mucin-derived glycans, the complex sugars that make up the gut’s protective mucus layer. Carbohydrate-active enzyme profiling captured this pivot: instead of harvesting energy from plant fiber, the farmer microbiome appeared increasingly specialized in grazing the host’s own mucus, a pattern that earlier studies have linked to diminished gut resilience.

The resistome followed an exposure gradient so clean it looked almost schematic: resistance gene abundance was highest in pigs, intermediate in farmers and lowest in residents, a pattern established through differential abundance testing with correction for false discovery. Farmers carried elevated levels of determinants conferring resistance to drug classes that dominate veterinary formularies — florfenicol, a phenicol antibiotic used extensively in swine production; quinolones; macrolide–lincosamide–streptogramin combinations; and aminoglycosides. Strikingly, genes conferring resistance to β-lactams, the antibiotic family that anchors human clinical medicine, were proportionally underrepresented in farmers. The resistome of a pig farmer, in other words, mirrors the drug cabinet of the barn rather than the pharmacy of the clinic. That pharmacological fingerprint matters epidemiologically, because the resistance genes a person carries shape the raw material available to their own future infections, and to the bacteria that circulate through their households and communities.

The study’s most consequential findings concerned not the resistance genes themselves but the vehicles that carry them. Bacteria trade DNA through mobile genetic elements, chief among them plasmids: self-replicating circles of DNA that can pass from cell to cell by conjugation and haul cargo genes, including resistance determinants, across species lines. When the team assembled and dereplicated plasmid sequences from the metagenomes, they recovered 157,298 nonredundant plasmid contigs, of which 1,415 carried antibiotic resistance genes. The distribution was stark: 83.1 percent of the ARG-bearing plasmid contigs were enriched in pigs, 18.3 percent in farmers and just 3.9 percent in residents. Most striking of all, 88.8 percent of the farmer-enriched plasmid contigs were also enriched in pigs, and they harbored genes of genuine clinical concern. Among them were optrA, the first transferable gene known to confer resistance to oxazolidinones such as linezolid, a last-resort antibiotic against multidrug-resistant Gram-positive infections; cfr, which compromises several antibiotic classes at once, including linezolid and pleuromutilins; and mcr-10.1, a member of the mobilized colistin resistance family, colistin being a polymyxin of last resort in human medicine. The picture that emerges is of a pig-centered plasmid reservoir, with farmer guts sitting directly in its shadow.

Plasmids were not the only mobile elements under scrutiny. The researchers also screened 227,476 phage contigs — the genomic signatures of bacteriophages, the viruses that infect bacteria — for resistance genes. Only 106 carried any, confirming that transduction, the viral route of gene transfer, is rare in this system. Yet the ARG-bearing phages that did surface were predominantly pig-associated, a small but pointed echo of the plasmid findings. Most gut phages are temperate, slipping into bacterial chromosomes and copying their hosts rather than killing them, which in principle lets them shuttle genes between lineages — but the numbers here show that route is a trickle, not a flood. The contrast between the two analyses is informative. Conjugative plasmids require only a local handshake between microbes that happen to share an intestine, whereas phage-mediated transfer depends on infection dynamics and host ranges. At the livestock–human interface, at least, plasmids appear to be the dominant conduit through which the animal resistome reaches human hosts.

To test whether whole bacteria were crossing hosts as well, the team sequenced the genomes of all 833 E. coli isolates and compared their multilocus sequence types and core-genome relationships, visualizing the population structure in a minimum spanning tree colored by host. The verdict on clonal transmission — the passage of an identical bacterial strain between hosts — was emphatically limited: across the entire cohort, the researchers identified just five pig-to-farmer and one pig-to-resident transmission events. E. coli populations were largely host-segregated, with pigs, farmers and residents each harboring distinct strain assemblages, and the isolates’ resistance phenotypes had been profiled across a panel of antibiotics. The isolates nonetheless told a consistent story about genes: pig and farmer isolates carried heavier genomic burdens of resistance determinants than resident isolates. The researchers also compared the genetic surroundings of tet(X4)-positive plasmids, which carry resistance to the last-line antibiotic tigecycline, in pigs and farmers, probing whether shared plasmid backbones underpinned the overlap. Taken together, the data support a model in which the bacteria themselves mostly stay put while their resistance cargo migrates — horizontal gene transfer, not microbial migration, is the engine of exchange at this interface.

The microbial signature of farm work is distinct enough that an algorithm can read it. Using a random-forest classifier — an ensemble of decision trees that vote on a category — trained on metagenomic taxonomic profiles alone, the team distinguished farmers from residents with an area under the curve of 0.921, a specificity of 0.90 and a sensitivity of 0.775. An AUC of 0.921 means the model ranked a randomly chosen farmer above a randomly chosen resident more than nine times out of ten, and it achieved this without any resistance gene data, implying that exposure leaves its mark on community structure itself. Two organisms emerged as candidate exposure biomarkers: Schaalia odontolytica, an actinobacterial species better known from the oral cavity, and Acinetobacter lwoffii, a hardy environmental bacterium often found in animal-associated settings. Neither is by itself a pathogen of alarm; their significance is diagnostic. If validated in independent cohorts, such microbial fingerprints could serve as inexpensive, noninvasive measures of occupational exposure, complementing workplace surveys and environmental monitoring.

The authors are careful about what their data can and cannot show. The study is cross-sectional — a snapshot rather than a film — so it demonstrates association, not direction. Whether farmers’ resistomes were seeded by the barn, continuously reinforced by it, or shaped by antibiotic use patterns that correlate with farm work cannot be resolved without the longitudinal, environment-integrated and strain-resolved follow-up studies the researchers themselves call for. Nor can metagenomic assemblies alone prove which direction a given plasmid traveled; shared enrichment in pigs and farmers is a strong clue, not a time-stamped itinerary. Whether resistance genes acquired at work persist after workers leave the industry, or ever reach their families and hospitals, likewise remains open. Even so, the implications reach well beyond Sichuan. Antimicrobial resistance is a One Health problem, and this study supplies some of the clearest evidence yet that the human gut operates as a downstream node of livestock microbial ecology — not by acquiring pig bacteria wholesale, but by quietly inheriting their genes. Funded by China’s National Key Research and Development Program and the National Natural Science Foundation of China and published open access, the work argues for veterinary antimicrobial stewardship, hygiene and exposure reduction not as abstractions but as protections for an invisible organ that, the data suggest, remembers where its owner works.

The study addresses a central problem in modern infectious-disease control: antibiotic resistance is not a single, uniform phenomenon. Different Salmonella lineages can acquire different resistance genes, lose them, or exchange them with unrelated bacteria. Invasive disease makes this problem especially urgent because treatment frequently begins before laboratory results are available. Clinicians may need to select an antibiotic based on local expectations, even though the infecting strain may have traveled across borders or acquired resistance in a distant setting. Genomic surveillance provides a way to see these hidden connections by comparing the DNA of bacterial isolates rather than treating every infection as an isolated event.

The researchers’ approach combines whole-genome sequencing with epidemiological and geographic analysis. Whole-genome sequencing reads the genetic material of each isolate at high resolution, allowing scientists to distinguish closely related strains and detect mutations or acquired DNA segments associated with drug resistance. Computational pipelines can identify known antimicrobial-resistance genes, changes in chromosomal targets, and mobile genetic elements such as plasmids. Plasmids are circular DNA molecules that can move between bacteria, sometimes carrying several resistance genes at once. When genomic data are linked to the date and location of sample collection, researchers can reconstruct evolutionary trees and estimate when resistant groups emerged, expanded, or moved between regions.

The analysis focuses on resistance considered a priority by the World Health Organization, a designation intended to direct attention toward threats that are difficult to treat and capable of causing substantial public-health harm. In Salmonella, resistance may compromise drugs used against invasive infections, including important classes relied upon when illness is severe. The significance of the findings lies not simply in detecting resistance genes, but in showing how they are distributed among bacterial lineages and how their prevalence changes over time. A resistance determinant found sporadically in unrelated strains suggests a different control challenge from one concentrated in a rapidly expanding international lineage.

The genomic picture indicates that resistant invasive Salmonella is being driven by multiple evolutionary processes rather than by one universal outbreak. Some resistance patterns are associated with the expansion of particular clonal groups—near-identical descendants of a common ancestor—while others appear to have been assembled through repeated horizontal gene transfer. In horizontal gene transfer, bacteria exchange genetic material directly or acquire DNA from their surroundings, enabling resistance to spread faster than ordinary reproduction alone would allow. This distinction matters for surveillance. Containing a single expanding lineage may require tracing transmission and interrupting its spread, whereas mobile resistance elements can demand broader monitoring across food systems, hospitals, communities, and animal populations.

The study’s spatial and temporal perspective is particularly important because Salmonella moves through interconnected ecological networks. Human infections can be linked to food production, livestock, poultry, wildlife, water, travel, and international trade. A strain detected in a hospital may reflect local transmission, but it may also represent an imported infection or a lineage circulating through a shared food or animal reservoir. By mapping related genomes across time and place, genomic surveillance can reveal whether resistance is emerging independently in several regions or spreading outward from established reservoirs. Such information can help public-health agencies determine where prevention should be concentrated and whether interventions are reducing transmission.

The findings also demonstrate why conventional surveillance alone can underestimate the threat. Routine monitoring often depends on phenotypic susceptibility testing, in which bacteria are grown in the presence of antibiotics to determine whether they are inhibited. This remains essential because it measures the organism’s actual response to treatment, but it may not explain how resistance is spreading. Genomic data can identify the genetic basis of resistance, uncover relationships between isolates, and detect combinations of genes that are likely to produce multidrug resistance. Conversely, genome-based prediction must be interpreted carefully: the presence of a gene does not always produce the same level of resistance, and some mechanisms remain incompletely characterized. The strongest systems therefore combine sequencing, laboratory testing, and clinical information.

For patients with invasive salmonellosis, the implications are immediate. When first-line therapy fails, bacteremia can persist and complications can become more severe, extending hospital stays and increasing the need for reserve antibiotics. The global patterns described in the study support a move toward faster, more integrated diagnostic systems capable of connecting a patient’s isolate to international databases. A genome generated within days could help identify a resistant lineage, alert clinicians to a possible treatment problem, and notify epidemiologists that apparently unrelated cases may be connected. Such systems are most useful when data are shared rapidly and consistently, with standardized methods that make results comparable across countries.

The researchers’ work ultimately presents antibiotic resistance as a moving target that must be monitored at the level of genes, lineages, populations, and ecosystems. Invasive Salmonella does not evolve in isolation, and its resistance profile can change as bacteria encounter antibiotics and exchange DNA in human, animal, and environmental settings. Global genomic surveillance cannot replace vaccination, food-safety measures, infection prevention, responsible antibiotic use, or improved access to diagnostics. It can, however, show where those measures are most urgently needed and reveal emerging threats before they become widely established. By turning scattered bacterial genomes into a dynamic map of evolution and transmission, the study offers a framework for detecting the next wave of priority resistance while there is still time to contain it.

Subject of Research: Global genomic surveillance of WHO-priority antibiotic resistance in invasive Salmonella

Article Title: Global genomic surveillance uncovers emergence and spatiotemporal patterns of World Health Organization priority antibiotic resistance in invasive Salmonella

Article References: Pei, Y., Yang, Z., Pang, X. et al. “Global genomic surveillance uncovers emergence and spatiotemporal patterns of World Health Organization priority antibiotic resistance in invasive Salmonella.” Nature Communications (2026). https://doi.org/10.1038/s41467-026-76354-1

Image Credits: AI Generated

DOI: 10.1038/s41467-026-76354-1

Keywords: invasive Salmonella, antibiotic resistance, antimicrobial resistance, genomic surveillance, whole-genome sequencing, WHO priority pathogens, bacterial evolution, infectious diseases, global health

Antimicrobial resistance, or AMR, occurs when bacteria and other microbes evolve the ability to survive medicines designed to kill them or stop their growth. Although resistance is often associated with clinical settings, antimicrobial compounds, resistant organisms, and resistance genes can also move through sewage systems, soil, rivers, and oceans. Wastewater is particularly important because it brings together bacteria from human populations, hospitals, households, and the surrounding environment. In these densely mixed microbial communities, bacteria can exchange genetic material through processes such as horizontal gene transfer, allowing resistance traits to spread between unrelated strains.

The researchers focused on Puerto Baquerizo Moreno, the principal city on San Cristóbal. Over a two-year period, they collected water from 16 marine locations, two freshwater sites, and two points within the municipal wastewater system containing raw sewage. Molecular tests revealed several coastal “hot spots” consistent with wastewater contamination. The contamination was linked to failures in the local treatment system, allowing sewage to flow toward or directly into the ocean rather than being properly processed. Because the Galápagos is both a protected ecosystem and a heavily visited region, the discharge creates a potential pathway for human-associated microbes and resistance genes to enter sensitive marine habitats.

A central innovation in the study was the development of a mobile field laboratory capable of performing much of the analysis on site. Conventional microbiology laboratories typically depend on refrigerators and freezers, specialized instruments, precise pipetting, and a stable electrical supply. Transporting samples back to such facilities can also introduce delays and contamination risks, while preserving biological material during shipment requires a reliable cold chain. The Penn team instead assembled a collection of compact instruments and reagents that could be carried in backpacks and operated in the field, with several devices controlled or monitored using a smartphone.

The portable laboratory included a small quantitative polymerase chain reaction, or qPCR, instrument and a nanopore sequencing device. qPCR detects and measures selected DNA sequences, enabling researchers to estimate the abundance of specific bacterial targets or resistance genes. Sequencing provides a broader view by reading genetic material and helping identify organisms, resistance determinants, and the genetic neighborhoods in which those determinants occur. The team also adapted sample preparation for field use. Reagents were placed in sealed, single-use chambers resembling contact-lens blister packs, reducing the need for conventional tubes and minimizing errors associated with precision pipetting.

The results showed that bacteria recovered from contaminated environments frequently displayed resistance to multiple antibiotics. Among the organisms that could be grown in culture, a large proportion were resistant to drugs from at least three antibiotic classes, meeting the definition of multidrug resistance. Culture-based methods do not capture every organism present in an environmental sample, since many bacteria cannot be readily grown under laboratory conditions. However, combining cultivation with molecular detection and sequencing allowed the researchers to examine both the resistance traits expressed by viable bacteria and the broader pool of resistance genes present in the water.

The genetic data raised particular concern. The researchers observed patterns suggesting that bacteria in the contaminated environment were acquiring, rearranging, and combining antimicrobial resistance genes. Bacteria can exchange DNA through mobile genetic elements, including plasmids, transposons, and integrons. These elements can carry one or several resistance genes and move among bacterial populations. When sewage introduces large numbers of bacteria and antibiotic residues into the same environment, it may increase opportunities for genetic exchange and selection. The study suggests that the Galápagos wastewater system is not merely releasing resistant bacteria but may also be contributing to an active environment in which novel resistance combinations arise.

The findings have implications beyond the islands. Lower- and middle-income countries bear a disproportionate share of the global AMR burden, yet environmental surveillance is often limited by the cost and complexity of laboratory infrastructure. A portable system that can perform molecular diagnostics and sequencing close to the sampling site could make it easier to identify contamination before it spreads widely. It could also support rapid investigations after wastewater failures, provide data for improving treatment systems, and help public-health agencies track resistance in regions where transporting samples to distant laboratories is impractical.

The project also incorporated local engagement and student training. Penn students spent the academic year learning laboratory methods, working with communities in the Galápagos, carrying out field sampling, and analyzing the resulting data. Researchers said that conducting the work in public view helped connect scientific investigation with everyday environmental concerns, including wastewater management and coastal health. Daniel P. Beiting and Lisa M. Mattei of Penn’s School of Veterinary Medicine are now continuing to adapt the mobile laboratory for use in communities that are even more remote. Their objective is to make environmental AMR surveillance more accessible while identifying infrastructure failures that allow resistant microbes to move from human settlements into ecosystems and, potentially, back into human populations.

Subject of Research: Not applicable

Article Title: Human wastewater contamination drives the emergence of multidrug-resistant bacteria in the Galápagos marine ecosystem

News Publication Date: 4-Aug-2026

Web References: https://www.nature.com/articles/s41467-026-74899-9; https://www.vet.upenn.edu/directory/danielbeiting/

References: Nature Communications, DOI: 10.1038/s41467-026-74899-9

Keywords: Antimicrobial resistance, antibiotic resistance, multidrug-resistant bacteria, wastewater contamination, marine ecology, Galápagos, environmental microbiology, qPCR, nanopore sequencing, wastewater treatment, resistance genes, public health

Researchers at Indiana University Bloomington, collaborating with Dartmouth College and the Georgia Institute of Technology, have unveiled the intricate molecular dance that powers these fibers’ extreme mechanical strength. Their findings, recently published in the prestigious Proceedings of the National Academy of Sciences, expose the synergy and coordination between motor proteins PilT and PilU. These proteins are essential for reeling in type IV pili — one of nature’s most forceful biological mechanisms — that allow bacteria to perform feats critical to infection and resistance propagation.

Type IV pili extend from a bacterial surface like whip-like tendrils, capable of retracting with astounding force. This process lies at the heart of pathogenicity for numerous bacteria. For instance, Pseudomonas aeruginosa anchors itself to lung tissue in cystic fibrosis patients via these pili, while Neisseria gonorrhoeae employs them to colonize the urogenital tract. Perhaps most crucially, Vibrio cholerae, the cholera-causing pathogen examined in this study, deploys type IV pili as molecular fishing rods, pulling in DNA that encodes antibiotic resistance, effectively accelerating the spread of drug resistance through horizontal gene transfer.

Understanding how bacteria muster such enormous force through these molecular motors has eluded scientists for years. It was clear that PilT and PilU operate in tandem to snap pili back inside the cell, but the necessity and coordination of this duo remained a mystery until now. Through innovative computational modeling powered by AlphaFold 3 — one of the most advanced protein-structure prediction tools — the team simulated interactions among PilT, PilU, and PilC, the protein anchoring the motor complex to the pilus machinery.

The revelations were groundbreaking. PilT acts as the linchpin anchoring the motor complex, while PilU cannot tether itself independently. Once both motors assemble, they stack and interlock through a unique PilU tail domain that loops around PilT, akin to a hand gripping a handle. This physical interplay appears to synchronize their activity, enabling the motors to function as a single cohesive unit. This was further corroborated by molecular dynamics simulations—sophisticated animations at the atomic level — which visualized the proteins’ coordinated motion over hundreds of nanoseconds, pinpointing the precise molecular interfaces responsible for their binding.

To validate these computational insights, the team carried out meticulous laboratory experiments that strategically disrupted the molecular contacts between PilT and PilU. Intriguingly, while these disruptions did not kill the bacteria outright, they severely impaired the bacterial ability to uptake exogenous DNA via pili retraction. This highlights that the physical integration and coordination of these motors, rather than their mere presence, are critical for bacterial acquisition of advantageous genetic traits, such as antibiotic resistance.

Lead author Abigail Teipen from Indiana University described these molecular motors as some of the most powerful known in nature, underscoring the significance of decoding their mechanism. “This coordination is not just about having two engines; it’s about how their interactions amplify force beyond the capability of either alone,” she explained. The team’s calculations indicate a single motor protein produces up to approximately 50 piconewtons of force. However, simultaneous action of both motors, facilitated by their tail-to-handle linkage, more than doubles this output, generating an extraordinary mechanical punch at an atomic scale.

The implications of this discovery stretch beyond cholera bacteria. Comparative analyses reveal that this molecular coordination is evolutionarily conserved across diverse pathogenic bacteria, including Acinetobacter baylyi, Pseudomonas aeruginosa, and Legionella pneumophila, the agent behind Legionnaires’ disease. This evolutionary footprint suggests that the sophisticated PilT-PilU partnership emerged early and remained indispensable for bacterial survival and virulence.

Understanding the forces driving pilus retraction and its coordination unlocks a promising avenue for therapeutic intervention. Interrupting the PilT-PilU interaction may hinder bacteria’s ability to acquire antibiotic resistance genes and reduce their capacity to colonize human tissues. Such targeted disruption focuses not on killing bacteria directly but on neutralizing their mechanical tools vital for infection and adaptation, potentially minimizing the selective pressure that accelerates resistance emergence.

This study exemplifies the power of integrative techniques in modern biology — leveraging cutting-edge computational modeling alongside rigorous molecular biology to resolve longstanding biological enigmas. As antibiotic resistance continues to threaten global health, insights like these offer crucial intelligence for designing next-generation antimicrobials that disarm pathogens mechanically rather than chemically.

The research, funded by the National Institutes of Health, underscores the transformative potential when computer science and biology converge. By peeling back the layers of molecular choreography behind bacteria’s powerful surface structures, scientists inch closer to innovative solutions against a looming public health crisis.

Subject of Research: Cells
Article Title: Structural modeling reveals the mechanism of motor ATPase coordination during type IV pilus retraction
News Publication Date: 8-Jun-2026
References: Proceedings of the National Academy of Sciences
Web References: https://pubmed.ncbi.nlm.nih.gov/42258723/

Keywords

Type IV pili, antibiotic resistance, bacterial motors, PilT, PilU, molecular dynamics, AlphaFold 3, horizontal gene transfer, biofilms, bacterial adhesion, Vibrio cholerae, Pseudomonas aeruginosa, Legionella pneumophila, protein coordination, infection mechanisms